The National Technical Advisory Group for Immunisation (NTAGI) has recommended introduction of The quadrivalent Human Papilloma Virus (qHPV) vaccine in the Universal Immunization Programme (UIP) with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction
Mumbai [Maharashtra], September 29 (ANI): MSD Pharmaceuticals on Wednesday announce the launch of India's first gender-neutral Human Papillomavirus (HPV) vaccine to help reduce HPV-related disease burden in the country.